Literature DB >> 16337614

Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery.

Majed A Refaai1, Rick W Wright, Curtis A Parvin, Ann M Gronowski, Mitchell G Scott, Charles S Eby.   

Abstract

BACKGROUND: Ischemia can alter the ability of albumin to bind free metal atoms. Based on these biochemical changes, methods to quantify ischemia modified albumin (IMA) were developed to assist in the evaluation of patients with symptoms of cardiac ischemia. Since ischemia can occur in any vascular bed, the specificity of IMA for cardiac muscle ischemia is unclear and requires further investigation.
METHODS: We evaluated the specificity of an IMA test in patients with skeletal muscle ischemia during arthroscopic knee surgery. A pressurized thigh cuff was continuously inflated to 300 mm Hg on the operative leg, in order to arrest blood flow during the procedure. Samples were collected before surgery, 15 min after surgery, and prior to discharge.
RESULTS: Twenty-three patients were enrolled in the study. Median tourniquet time was 29 min (range 19-108). Median pre-operative IMA was 90.2 KU/l (range 77-101.6). Statistically significant (p<0.05) increases in IMA and myoglobin concentrations, and decreases in albumin concentrations were observed following tourniquet release and before discharge.
CONCLUSIONS: Post-operative myoglobin elevations indicated that skeletal muscle ischemia was sufficient to produce detectable myocyte necrosis. Post-operative IMA increases are consistent with ischemic modification of albumin during exposure to ischemic conditions in skeletal muscle during and /or immediately after tourniquet application. However, the negative correlations between IMA and albumin results suggest that increases in IMA were in part due to lower post-operative albumin concentrations resulting in decreased cobalt binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337614     DOI: 10.1016/j.cca.2005.10.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Ischemic heart diseases in Egypt: role of xanthine oxidase system and ischemia-modified albumin.

Authors:  Ola Sayed Ali; Hanan Muhammad Abdelgawad; Makram Sayed Mohammed; Rehab Refaat El-Awady
Journal:  Heart Vessels       Date:  2013-10-04       Impact factor: 2.037

2.  The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.

Authors:  Prashanth Ashok Kumar; Kavitha Subramanian
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma?

Authors:  Hamit Yasar Ellidag; Nurullah Bulbuller; Esin Eren; Sedat Abusoglu; Evren Akgol; Mustafa Cetiner; Necat Yılmaz
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

4.  Correlation of ischemia-modified albumin levels and histopathologic findings in experimental ovarian torsion.

Authors:  Ahmet Yildirim; Sule Yildirim; Naci Topaloglu; Mustafa Tekin; Adem Kucuk; Havva Erdem; Mesut Erbas; Dilek Ulker Cakir
Journal:  Turk J Emerg Med       Date:  2016-03-10

5.  The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations.

Authors:  Firat Uygur; Hakan Tanriverdi; Murat Can; Tacettin Ornek; Fatma Erboy; Bulent Altinsoy; Figen Atalay; Murat Damar; Furuzan Kokturk; Meltem Tor
Journal:  Mediators Inflamm       Date:  2016-01-20       Impact factor: 4.711

6.  One-lung ventilation duration-dependent stress response in thoracotomies and the effect of a low-volume, high-frequency differentiated ventilation strategy on this response.

Authors:  Şükran Geze; Celal Tekinbaş; Hülya Ulusoy; Ahmet Menteşe; Murat Topbaş; Mesut Karaca
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-14       Impact factor: 0.332

7.  The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism.

Authors:  Suleyman Turedi; Abdulkadir Gunduz; Ahmet Mentese; Murat Topbas; Suleyman C Karahan; Selman Yeniocak; Ibrahim Turan; Oguz Eroglu; Utku Ucar; Yunus Karaca; Suha Turkmen; Robert M Russell
Journal:  Respir Res       Date:  2008-05-30

Review 8.  Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient.

Authors:  Anthony S McLean; Stephen J Huang; Mark Salter
Journal:  Crit Care       Date:  2008-06-02       Impact factor: 9.097

9.  The effects of spinal, inhalation, and total intravenous anesthetic techniques on ischemia-reperfusion injury in arthroscopic knee surgery.

Authors:  Müge Koşucu; Ilker Coşkun; Ahmet Eroglu; Dilek Kutanis; Ahmet Menteşe; S Caner Karahan; Emre Baki; Servet Kerimoğlu; Murat Topbas
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

10.  Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.

Authors:  Amit R Nayak; Rajpal S Kashyap; Dinesh Kabra; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Ann Neurosci       Date:  2011-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.